Key result
Total cholesterol levels were lower in deceased cancer patients and were a significant predictor of mortality.
Why the study?
Cardiovascular diseases and cancer share common risk factors, but the relationship between cholesterol levels and mortality in patients undergoing cancer treatment remains to be evaluated.
Are total cholesterol levels associated with mortality in patients receiving anticancer treatment under cardiological surveillance?
Cohort (n=551)
Are total cholesterol levels associated with mortality in patients receiving anticancer treatment under cardiological surveillance?
Lower total cholesterol levels are associated with increased mortality in cancer patients undergoing cardiological surveillance, highlighting a potential prognostic marker in cardio-oncology.
Answers are grounded in this paper and cite their sources.
Lower cholesterol may signal higher mortality risk in cancer; this Level 5 finding leaves open causality and requires prospective validation.
Cardiovascular (CV) diseases and cancer share several similarities, including common risk factors. In the present investigation we assessed the relationship between cholesterol levels and mortality in a cardiooncological collective. In total, 551 patients receiving anticancer treatment were followed over a median of 41 (95% CI 40, 43) months and underwent regular cardiological surveillance. A total of 140 patients (25.4%) died during this period. Concomitant cardiac diseases were more common in patients who deceased (53 (37.9%) vs. 67 (16.3%), p < 0.0001), as well as prior stroke. There were no differences in the distribution of classical CV risk factors, such as hypertension, diabetes or nicotine consumption. While total cholesterol (mg/dL) was significantly lower in patients who deceased (157 ± 59 vs. 188 ± 53, p < 0.0001), both HDL and LDL cholesterol were not differing. In addition, cholesterol levels varied between different tumour entities; lowest levels were found in patients with tumours of the hepatopancreaticobiliary system (median 121 mg/dL), while patients with melanoma, cerebral tumours and breast cancer had rather high cholesterol levels (median > 190 mg/dL). Cholesterol levels were significantly lower in patients who died of cancer; lowest cholesterol levels were observed in patients who died of tumours with higher mitotic rate (mesenchymal tumours, cerebral tumours, breast cancer). Cox regression analysis revealed a significant mortality risk for patients with stem cell transplantation (HR 4.31) and metastasised tumour stages (HR 3.31), while cardiac risk factors were also associated with a worse outcome (known cardiac disease HR 1.58, prior stroke/TIA HR 1.73, total cholesterol HR 1.70), with the best discriminative performance found for total cholesterol (p = 0.002).
No takes yet. Share an insight, caveat, or question.
Hohneck et al. (2021) conducted a cohort in Cancer (n=551). Total cholesterol was evaluated on Mortality (HR 1.70, p=0.002). Total cholesterol levels were lower in deceased cancer patients and were a significant predictor of mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: